<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bueno DF</submitter><funding>PROADI-SUS</funding><pagination>501</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7687766</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Bone reconstruction in congenital craniofacial differences, which affect about 2-3% of newborns, has long been the focus of intensive research in the field of bone tissue engineering. The possibility of using mesenchymal stromal cells in regenerative medicine protocols has opened a new field of investigation aimed at finding optimal sources of multipotent cells that can be isolated via non-invasive procedures. In this study, we analyzed whether levator veli palatini muscle fragments, which can be readily obtained in non-invasive manner during palatoplasty in cleft palate patients, represent a novel source of MSCs with osteogenic potential.&lt;h4>Methods&lt;/h4>We obtained levator veli palatini muscle fragments (3-5 mm&lt;sup>3&lt;/sup>), during surgical repair of cleft palate in 5 u</pubmed_abstract><journal>Stem cell research &amp; therapy</journal><pubmed_title>Human levator veli palatini muscle: a novel source of mesenchymal stromal cells for use in the rehabilitation of patients with congenital craniofacial malformations.</pubmed_title><pmcid>PMC7687766</pmcid><funding_grant_id>25000.009809/2018-65</funding_grant_id><pubmed_authors>Rocha DL</pubmed_authors><pubmed_authors>Shibuya Y</pubmed_authors><pubmed_authors>Kabayashi GS</pubmed_authors><pubmed_authors>Tanikawa DYS</pubmed_authors><pubmed_authors>Raposo-Amaral CE</pubmed_authors><pubmed_authors>ZuK PA</pubmed_authors><pubmed_authors>Ferreira JRM</pubmed_authors><pubmed_authors>Passos-Bueno MR</pubmed_authors><pubmed_authors>Hokugo A</pubmed_authors><pubmed_authors>Jarrahy R</pubmed_authors><pubmed_authors>Bueno DF</pubmed_authors><pubmed_authors>Pinheiro CCG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Human levator veli palatini muscle: a novel source of mesenchymal stromal cells for use in the rehabilitation of patients with congenital craniofacial malformations.</name><description>&lt;h4>Background&lt;/h4>Bone reconstruction in congenital craniofacial differences, which affect about 2-3% of newborns, has long been the focus of intensive research in the field of bone tissue engineering. The possibility of using mesenchymal stromal cells in regenerative medicine protocols has opened a new field of investigation aimed at finding optimal sources of multipotent cells that can be isolated via non-invasive procedures. In this study, we analyzed whether levator veli palatini muscle fragments, which can be readily obtained in non-invasive manner during palatoplasty in cleft palate patients, represent a novel source of MSCs with osteogenic potential.&lt;h4>Methods&lt;/h4>We obtained levator veli palatini muscle fragments (3-5 mm&lt;sup>3&lt;/sup>), during surgical repair of cleft palate in 5 u</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Nov</publication><modification>2026-04-30T06:23:03.217Z</modification><creation>2021-02-20T03:03:52Z</creation></dates><accession>S-EPMC7687766</accession><cross_references><pubmed>33239080</pubmed><doi>10.1186/s13287-020-02017-7</doi></cross_references></HashMap>